BACK TO CONTENTS   |    PDF   |    PREVIOUS   |    NEXT

Title

Homology modelling of CB1 receptor and selection of potential inhibitor against Obesity

 

Authors

Mahesh Shrinivasan1*, Sinosh Skariyachan2, Vaka Aparna1 & Vinod Rama Kolte1

 

Affiliation

1Department of Biotechnology, Dayananda Sagar College of Arts, Science & Commerce, Bangalore, India; 2R & D Centre, Department of Biotechnology, Dayananda Sagar College of Engineering, Bangalore, India

 

Email

mahesh_3s89@yahoo.co.in; *Corresponding author

 

Article Type

Hypothesis

 

Date

Received June 04, 2011; Accepted June 08, 2011; Published June 16, 2012

Abstract

Obesity and patient morbidity has become a health concern worldwide. Obesity is associated with over activity of the endocannabinoid system, which is involved in the regulation of appetite, lipogenesis and insulin resistance. Hypothalamic cannabinoid-1 receptor (CB1R) inverse agonists reduce body weight and improve cardiometabolic abnormalities in experimental and human obesity but displayed neuropsychiatric side effects. Hence, there is a need to develop therapeutics which employs blocking peripheral CB1 receptors and still achieve substantial weight loss. In view of the same, adipose tissue CB1 receptors are employed for this study since it is more specific in reducing visceral fat. Computer aided structure based virtual screening finds application to screen novel inhibitors and develop highly selective and potential drug. The rational drug design requires crystal structure for the CB1 receptor. However, the structure for the CB1 receptor is not available in its native form. Thus, we modelled the crystal structure using a lipid G-Protein coupled receptor (PDB: 3V2W, chain A) as template. Furthermore, we have screened a herbal ligand Quercetin [- 2- (3, 4-dihydroxyphenyl) - 3, 5, 7-trihydroxychromen-4-one] a flavonol present in Mimosa pudica based on its better pharmacokinetics and bioavailability profile. This ligand was selected as an ideal lead molecule. The docking of quercetin with CB1 receptor showed a binding energy of -6.56 Kcal/mol with 4 hydrogen bonds, in comparison to the known drug Rimonabant. This data finds application in proposing antagonism of CB1 receptor with Quercetin, for controlling obesity.

 

Keywords

Obesity, Cannabinoid receptor 1, CB1 inverse agonists, Quercetin, Rimonabant

Citation

Shrinivasan et al. Bioinformation 8(11): 523-528 (2012)
 

Edited by

P Kangueane

 

ISSN

0973-2063

 

Publisher

Biomedical Informatics

 

License

This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.